Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2009
10/14/2009CN100548315C Silkworm health-care product and its preparing process
10/14/2009CN100548312C Method of preparing biologically active substance liquid capsule
10/14/2009CN100548309C Stavudine sustained release tablet
10/14/2009CN100548307C Medicine for treating cardiocerebral vascular diseases
10/14/2009CN100548305C Compound vibramycin injection for animals and the preparing method thereof
10/14/2009CN100548302C Female hormone-containing patch
10/14/2009CN100548301C Injection for curing diarrhea of pig and preparation thereof
10/14/2009CN100548298C Pantoprazole sodium liposomes freeze-dry preparations and method of preparing the same
10/14/2009CN100548297C Slow release drop pills comprising toraesmide active ingredient and method for preparing same
10/14/2009CN100548295C Aztreonam liposomes freeze-dry preparations and method of preparing the same
10/14/2009CN100548287C Percutaneous absorption preparation
10/14/2009CN100548286C A solid dispersion of ambroxol hydrochloride and composition thereof
10/14/2009CN100548285C Terbinafine nano milk antifungal medicine and its preparation
10/14/2009CN100548284C Microemulsion of hypocrellin, and its preparing method
10/14/2009CN100548282C Medicine for treating liver cancer
10/14/2009CN100548281C Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
10/14/2009CN100548280C Tablets containing enrofloxacin and flavouring agents and/or flavours
10/14/2009CN100548279C Delayed total release gastrointestinal drug delivery system
10/14/2009CN100548278C New preparation method for raising rate of packaging microspheres of naltrexone
10/14/2009CN100548277C Preparing method of powder agglomerates
10/14/2009CN100548276C Melt-formulated, multi-particulate oral dosage form
10/14/2009CN100548275C Virosome-like-particles
10/14/2009CN100548274C Water type injection containing paclitaxel and its preparing method
10/14/2009CN100548273C Instant cordate houttuynia gel preparation for eye
10/14/2009CN100548272C Composition comprising colony stimulating factor for treatment of a localized bacterial infection and bacterial related disease
10/14/2009CN100548271C Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
10/14/2009CN100548270C Pharmaceutical composition for improving palatability of drugs and process for preparation thereof
10/14/2009CN100548228C Composition and apparatus for transdermal delivery
10/14/2009CN100548150C Preparation of coconut extractive
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/13/2009US7601523 Method for production of arachidonic acid
10/13/2009US7601518 Secretion of neublastin
10/13/2009US7601515 Process of high purity albumin production
10/13/2009US7601367 Delivering a siRNA to a mammal cell; low toxicity
10/13/2009US7601366 Promotion of peroxisomal catalase function in cells
10/13/2009US7601363 Water solubility; silicones; vaccines
10/13/2009US7601361 Treating with formaldehyde; durability; polyamides, polyurethanes and polyureas as substrates; hydroxymethylation catalysts
10/13/2009US7601360 Excitatory amino acid inhibitors for treating sensitive skins
10/13/2009US7601347 Methods and compositions for controlled release of bioactive compounds
10/13/2009US7601338 Dentifrice and mouthwash compositions comprising an enzyme having waterinsoluble impurities and a cyclodextrin which complexes with the impurity to form a waterform an insoluble complex; papain or other proteolytic enzymes; impurities including lipohilic and sulfur compounds;ketones; organoleptic
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009US7601336 Propellant containing a hydrofluoroalkane, a cosolvent and further comprising a low volatility component to increase the mass median aerodynamic diameter of the aerosol particles on actuation of the inhaler
10/13/2009US7601148 Infusion pump
10/13/2009US7600703 Particle-size reduction apparatus and use thereof
10/13/2009CA2602188C Dosage forms of risedronate
10/13/2009CA2483916C Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
10/13/2009CA2482405C Multiple compartment bag assembly for dialysis fluid
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2453624C Apparatus and method for self-induced cough-cardiopulmonary resuscitation
10/13/2009CA2447807C Abuse resistant pharmaceutical composition containing capsaicin
10/13/2009CA2445276C Aripiprazole oral solution
10/13/2009CA2438910C Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes
10/13/2009CA2419471C Use of triazinetrione sulphones for controlling coccidioses
10/13/2009CA2414665C Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
10/13/2009CA2408716C Stable polymeric micelle-type drug composition and method for the preparation thereof
10/13/2009CA2395866C Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/13/2009CA2395438C Dry compositions containing hydrophobic amino acid
10/13/2009CA2392620C Use of melatonin for the treatment of androgenetic and diffuse alopecia
10/13/2009CA2373867C Compositions comprising organosiloxane resins for delivering oral care substances
10/13/2009CA2367615C Transdermal therapeutic system with nicotine and addition of monoterpene ketones
10/13/2009CA2352625C Cleavable solid dosage forms and method for the production thereof
10/13/2009CA2351463C Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
10/13/2009CA2326715C Hemoglobin-polysaccharide conjugates
10/13/2009CA2323925C Crosslinkable macromers bearing initiator groups
10/13/2009CA2319515C Anhydrous topical skin preparations
10/13/2009CA2309278C Biodegradable, anionic polymers derived from the amino acid l-tyrosine
10/13/2009CA2217485C Controlled release biodegradable nanoparticles containing insulin
10/13/2009CA2187355C An adjunctive polymer system for use with medical device
10/13/2009CA2180810C Stable gelatin coated acetylsalicylic acid tablets
10/13/2009CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/08/2009WO2009123930A1 Device, system and method for measuring cross-sectional areas in luminal organs
10/08/2009WO2009123903A1 Hemostatic microspheres
10/08/2009WO2009123768A2 Nanocarrier and nanogel compositions
10/08/2009WO2009123759A2 Therapeutic uses of biocompatible biogel compositions
10/08/2009WO2009123580A1 Chewable tablet and method of formulating
10/08/2009WO2009123304A1 Fine granules having improved suspension performance in water
10/08/2009WO2009123257A1 Soft capsule coating and soft capsule
10/08/2009WO2009123242A1 Method for manufacturing unsymmetric laminated preparation
10/08/2009WO2009123207A1 Oral rinse composition
10/08/2009WO2009123169A1 Amide derivative-containing pharmaceutical composition
10/08/2009WO2009123103A1 Apparatus for producing liposomes and method of producing liposomes
10/08/2009WO2009123102A1 Processed starch powder with excellent disintegration properties and manufacturing method thereof
10/08/2009WO2009123003A1 Composition for external application to skin
10/08/2009WO2009122710A1 Medical composition
10/08/2009WO2009122431A2 Oral controlled release tablet
10/08/2009WO2009122404A2 Device for in situ production and topical administration of allicin
10/08/2009WO2009122301A2 Rasagiline mesylate particles and process for the preparation thereof
10/08/2009WO2009122288A2 Liquid and freeze dried formulations
10/08/2009WO2009122280A1 Pharmaceutical composition and diagnostic and therapeutic use thereof
10/08/2009WO2009121997A2 Pegylated nanoparticles containing a biologically active molecule and use thereof
10/08/2009WO2009121961A1 Cross-linked polymer matrix, in particular for administering active ingredients
10/08/2009WO2009121957A1 Toltrazuril with improved dissolution properties
10/08/2009WO2009121935A2 Pharmaceutical composition with bisphosphonate
10/08/2009WO2009121871A1 Pharmaceutical composition comprising candesartan
10/08/2009WO2009121629A1 Solubilisation method
10/08/2009WO2009121585A1 Pharmaceutical preparation comprising permethylated cyclodextrin
10/08/2009WO2009121514A2 Self-destructing transdermal therapeutic system having improved functionality and efficacy
10/08/2009WO2009121178A1 Novel oral controlled release pharmaceutical formulations
10/08/2009WO2009102467A3 Devices, formulations, and methods for delivery of multiple beneficial agents
10/08/2009WO2009100435A3 Sclerotherapy for varicose veins
1 ... 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 ... 2991